Αρχειοθήκη ιστολογίου

Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174

Τρίτη 8 Σεπτεμβρίου 2015

! ORL via Alexandros G.Sfakianakis on Inoreader: ENT mucormycosis. Report of 4 cases

! ORL via Alexandros G.Sfakianakis on Inoreader
 
ENT mucormycosis. Report of 4 cases
Sep 8th 2015, 11:21

Publication date: Available online 7 September 2015
Source:European Annals of Otorhinolaryngology, Head and Neck Diseases
Author(s): Wassim Kermani, Rachida Bouttay, Malek Belcadhi, Hounaida Zaghouani, Moncef Ben Ali, Mouhamed Abdelkéfi
ObjectivesMucormycosis is an opportunist infection usually affecting immunocompromised patients. It is rare and often fatal. The pathogen is filamentous fungus of the mucorales order. Studies discuss the clinical, diagnostic and therapeutic aspects of ENT mucormycosis, insisting on early clinical diagnosis, laboratory data not being contributive within satisfactory time limits.Material and methodsA retrospective study included 4 patients with ENT mucormycosis diagnosed over a 13-year period, from January 2000 to December 2012.ResultsThe study included 2 male and 2 female patients, aged from 3 to 77 years. Two patients were diabetic. There were 2 cases of sinonasal mucormycosis and 2 of otologic involvement. Diagnosis was founded on anatomopathologic and mycologic examination. A fatal issue occurred in 1 case with otocerebral involvement.ConclusionsOtorhinolaryngologic mucormycosis is a rare fungal infection, which needs to be borne in mind. Rhinocerebral lesions are the most common clinical manifestations. Involvement of the ear is very rare. Diagnosis is often difficult, but should be as early as possible. Treatment, initiated urgently, associates antifungal treatment, surgical resection and control of risk factors. The prognosis remains in all cases severe.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου